In a recent article at PharmaTech, they talk about the emerging opportunities in the biosimiars market. There are three main players that are in prime position to benefit in this market: leading business developers, smaller biosimilar focused companies and emerging biosimilar players. For an in depth look at who stands where, read the Pharma Tech article
here.
If you're interested in networking with other professionals in the biosimilars field, join our
LinkedIn group or follow our
Biosimilars Twitter.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment